Acusphere
Speciality pharmaceutical company developing cardiovascular drugs for the detection of coronary artery disease.
Launch date
Employees
Market cap
€3.2m
Enterprise valuation
€3m (Public information from Sep 2024)
Share price
$0.00001 ACUS
Lexington Kentucky (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$19.0m | Late VC | ||
N/A | N/A | IPO | |
N/A | $7.5m | Early VC | |
N/A | $2.5m | Debt | |
N/A | $100k | Convertible | |
Total Funding | €24.2m |
Related Content
Recent News about Acusphere
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.